On July 21, 2022 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported that it will host a conference call and webcast at 4:30pm ET on Thursday, August 4, 2022, to report its second quarter 2022 financial results, and provide a corporate update (Press release, Gritstone Oncology, JUL 21, 2022, View Source [SID1234616849]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the conference call, dial 800-263-0877 five minutes prior to the start of the call and provide the event title: Gritstone bio Second Quarter 2022 Earnings Call, or the following passcode: 8108859.

To access the webcast, visit View Source;tp_key=4f6eab0ea9

The archived webcast will be available on Gritstone’s website at View Source shortly following the conference call and will be available for at least 30 days following the call.